MOHW would cancel Innovative Pharmaceutical Certificate for stock price manipulation and sexual harassment

Published: 2018-03-15 14:04:04

Updated: 2018-03-15 14:04:04

The pharmaceutical innovation certification will be restricted and cancelled if a company is exposed of a company’s unethical activities by their employees.

On the 14^th, the Ministry of Health and Welfare(Ministry Neung-Hoo Park, MOHW) will pre-announced the ‘Partial Revision Bill to the Innovative Pharmaceutical Company Certificate’ which was created to raise ‘social responsibility and ethnic...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.